Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for Parkinson disease 19B, early-onset.
2 publications have been identified in PubMed for Parkinson disease 19B, early-onset. Research spans Review / Meta-Analysis (50%) and Case Report / Case Series (50%).
Alluqmani M (2024). [PMID: 39568674](https://pubmed.ncbi.nlm.nih.gov/39568674/). *Front Genet*. [Case Report / Case Series]
Ćwiklińska A (2024). [PMID: 39125813](https://pubmed.ncbi.nlm.nih.gov/39125813/). *Int J Mol Sci*. [Review / Meta-Analysis]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 5:50 AM UTC
Common questions about Parkinson disease 19B, early-onset
AI-curated news mentioning Parkinson disease 19B, early-onset
Updated Feb 20, 2026
The Parkinson disease research pipeline is rapidly evolving, with ongoing trials focusing on symptomatic therapies, disease-modifying strategies, and biomarker refinement. These studies are expected to significantly influence long-term treatment decisions in the management of Parkinson disease.